Mild acne
Conditions
Interventions
control group:Provide the control sample to the subjects and instruct them to use the sample as required.
Experimental group:Give the experimental sample to the subjects and require them to use the sample as specified.
Sponsors
Dematology Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Healthy females or males aged 18 to 60 years old; 2.Clinically diagnosed with mild acne and having 3 or more red pimples on the face. 3.Subjectively feel that the skin is sensitive; 4.Without allergic diseases and having no history of allergy to cosmetics or other topical preparations. 5.Have good compliance with this project and possess excellent communication skills. 6.Be willing to undergo follow-up and relevant non-invasive tests. 7.Those who can understand the experimental process, voluntarily participate in the experiment, and sign the written informed consent form.
Exclusion criteria
Exclusion criteria: 1.Those who have a history of skin diseases such as psoriasis, eczema, atopic dermatitis, severe acne, etc.; or those who suffer from other chronic systemic diseases. 2.Those who have taken anti-inflammatory drugs such as corticosteroid hormones orally or applied them topically within the past month. 3.Those who have used products or medications that affect skin color, such as alpha-hydroxy acids, salicylic acid, or preparations like hydroquinone, within the past two months. 4.Those who have used retinoid preparations on the test area or undergone medical aesthetic treatments such as chemical peeling, laser treatment, intense pulsed light treatment, etc. within the past three months. 5.Those who inevitably have long-term exposure to sunlight. 6.Those who have participated in other clinical trials within the past two months. 7.Those who have been diagnosed as having moderate to severe acne by clinicians. 8.Women who are planning to get pregnant, are pregnant, or are breastfeedin; 9.Those who have obvious scars, pigmentation, atrophy, nevus flammeus, sunburn spots, wounds, hirsutism, abrasions, tattoos or other blemishes at or near the skin test site, which will affect the determination of the test results. 10.Those with a highly sensitive constitution, and those who are known to be allergic to the ingredients of cosmetics or daily chemical products, alcohol, rubber, drugs, etc. 11.Those with other iatrogenic problems that may affect the test results (such as a history of coagulation dysfunction, severe hyperglycemia, hypertension, hyperlipidemia, mental illness, or other major diseases). 12.Those who are considered unsuitable to participate in the trial according to other clinical evaluations. 13.Those who do not participate voluntarily or are unable to complete the specified test content as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The volume of acne; | — |
Secondary
| Measure | Time frame |
|---|---|
| Transepidermal water loss;VISIA CR red area value; | — |
Countries
China
Contacts
Public ContactYe Li
Dematology Hospital of Southern Medical University
Outcome results
None listed